Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
02/2003
02/20/2003WO2002079387A3 Modular molecular clasps and uses thereof
02/20/2003WO2002068605A3 Non-oligomerizing tandem fluorescent proteins
02/20/2003WO2001072325A9 Methods of blocking tissue destruction by autoreactive t cells
02/20/2003US20030036631 Protein for use in the treatment of asthma, leukemia, or other allergic or inflammatory defects
02/20/2003US20030036511 Preparation of pure isoforms using TSK sulfopropyl cation exchange chromatography and reverse phase high performance liquid chromatography.
02/20/2003US20030036199 Kit for use in the diagnosis and treatment of cancer
02/20/2003US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
02/20/2003US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
02/20/2003US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
02/20/2003US20030036166 ErbB4 receptor-specific neuregulin related ligands and uses therefor
02/20/2003US20030035816 Soluble ctla4 mutant molecules and uses thereof
02/20/2003US20030035793 Novel immune response targeting molecules
02/20/2003CA2457059A1 System for detecting protease
02/20/2003CA2456236A1 Methods of screening based on the egf receptor crystal structure
02/20/2003CA2456117A1 Chimeric protein and its use in electron transfer methods
02/20/2003CA2453995A1 Tacis and br3 polypeptides and uses thereof
02/20/2003CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer
02/19/2003EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer
02/19/2003EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
02/19/2003EP1283875A1 Improved nucleic acid modifying enzymes
02/19/2003EP1283869A2 Novel bee venom polypeptides and methods of use thereof
02/19/2003EP1283849A2 Human receptor proteins; related reagents and methods
02/19/2003EP1283848A2 Protein complexes and assays for screening anti-cancer agents
02/19/2003CN1101937C Methodology for selecting superagonists, antagonists and superantagonist of hormones whose receptor complex includes GP 130
02/18/2003US6521749 GL50 nucleic acids and uses therefor
02/18/2003US6521746 Leukotoxin polypeptide fused to gonadotropin releasing hormone/factor multimer; increased immunogenicity
02/18/2003US6521741 Catalytic antibodies and a method of producing same
02/18/2003US6521602 Anti-neoplastic compositions and uses thereof
02/18/2003US6521422 Fhm, a novel member of the TNF ligand supergene family
02/18/2003US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders
02/18/2003US6521404 Gene expression of library bacteriophage particles with very light domain antibodies and synthetic very heavy antibodies displayed on surface
02/18/2003US6521230 CD25 binding molecules
02/18/2003CA2075366C Immunologically active peptides or polypeptides from the parvovirus b19
02/13/2003WO2003012441A1 Method for detecting modulators of notch signalling
02/13/2003WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer
02/13/2003WO2003012069A2 Compositions and methods for generating chimeric heteromultimers
02/13/2003WO2003012068A2 Novel fusion proteins and assays for molecular binding
02/13/2003WO2003012045A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
02/13/2003WO2003011909A1 Binding agents with differential activity
02/13/2003WO2003011878A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
02/13/2003WO2003011332A1 Methods relating to improved polyepitope vaccination strategies
02/13/2003WO2003011331A2 Materials and methods relating to improved vaccination strategies
02/13/2003WO2003011317A1 Modulators of notch signalling for use in immunotherapy
02/13/2003WO2002069232A3 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity
02/13/2003WO2002066514A3 Artificial fusion proteins with reduced immunogenicity
02/13/2003WO2002038805A3 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
02/13/2003WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
02/13/2003WO2001085763A3 Chimeric peptide immunogens their preparation and use
02/13/2003US20030032160 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis
02/13/2003US20030031669 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
02/13/2003CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
02/13/2003CA2494304A1 Materials and methods relating to improved vaccination strategies
02/13/2003CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
02/13/2003CA2455237A1 Compositions and methods for generating chimeric heteromultimers
02/13/2003CA2454937A1 Modulators of notch signalling for use in immunotherapy
02/13/2003CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer
02/12/2003EP1282706A2 Natrium-calcium exchanger protein
02/12/2003EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor
02/12/2003EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same
02/12/2003EP1282646A2 Human monoclonal antibodies to dendritic cells
02/12/2003EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
02/11/2003US6518487 Isolated nucleic acid; increases transformation efficiency; use to control cell division and cell cycle regulation
02/11/2003US6518403 Antibodies that bind an adipocyte-specific protein homolog
02/11/2003US6518062 Enzyme combinations for destroying proliferative cells
02/11/2003US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent
02/11/2003CA2162880C Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
02/11/2003CA2133843C Melanocyte stimulating hormone receptor and uses
02/11/2003CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region
02/06/2003WO2003010204A1 Process for preparation of polypeptides of interest from fusion peolypeptides
02/06/2003WO2003010202A1 Concatameric immunoadhesion
02/06/2003WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003WO2003010192A2 An inducer of apoptosis
02/06/2003WO2003009815A2 Compositions and methods for modulating blood-brain barrier transport
02/06/2003WO2002063005A3 Lipid-associated molecules
02/06/2003WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/06/2003WO2002032925A9 Protein scaffolds for antibody mimics and other binding proteins
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002019963A3 Synthetic erythropoiesis stimulating proteins
02/06/2003WO2002016413A8 Cripto tumour polypeptide
02/06/2003WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
02/06/2003US20030027774 For diagnosis and therapy of tuberculosis
02/06/2003US20030027283 Protein l and hybrid proteins thereof
02/06/2003US20030027247 Antigen binding unit for use in human diagnostics and therapeutics
02/06/2003US20030027220 Chemical modification
02/06/2003US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
02/06/2003CA2455681A1 An inducer of apoptosis
02/06/2003CA2454469A1 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003CA2450073A1 Compositions and methods for modulating blood-brain barrier transport
02/05/2003EP1281770A2 Human brain phosphodiesterase and screening method
02/05/2003EP1280930A1 Gamma secretase substrates and in vitro assays
02/05/2003EP1280904A2 Pain signaling molecules
02/05/2003EP1280903A2 Ph domain-interacting protein
02/05/2003EP1280900A2 Dendritic cell co-stimulatory molecules
02/05/2003EP1280566A2 Growth factor modified protein matrices for tissue engineering
02/05/2003EP0574512B1 Redirection of cellular immunity by receptor chimeras
02/05/2003CN1394956A Human epidermal growth factor receptor specific fusion protein and its application
02/05/2003CN1394954A Fusion protein with function of resisting tumor and its application
02/04/2003US6515107 Human metabotropic glutamate receptor 7 subtypes
02/04/2003US6515105 Vascular Endothelial Growth Factor binding to extracellular domain of NP-1 (Neuropilin-1); bioactive complexes; mediate useful cell responses or antagonize undesired biological activities; angiogenesis; cell differentiation
02/04/2003US6514498 Modified/chimeric superantigens and their use
1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 295